LIONVILLE, Pa., Jan. 7 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE:WST) today announced that Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, and William Federici, Chief Financial Officer, will attend CJS Securities' 10th Annual "New Ideas for the New Year" investor conference in New York, NY. Management will present an overview of West's business and outlook on Thursday, January 14, 2010 at 4:00 PM ET. About West West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at http://www.westpharma.com/. Contacts: West Pharmaceutical Services, Inc. Investors and Financial Media: Michael A. Anderson Westwicke Partners Vice President and Treasurer John Woolford/Stefan Loren (610) 594-3345 (443) 213-0506/0507 DATASOURCE: West Pharmaceutical Services, Inc. CONTACT: Michael A. Anderson, Vice President and Treasurer, West Pharmaceutical Services, Inc., +1-610-594-3345; For Investors and Financial Media: John Woolford, Westwicke Partners, +1-443-213-0506, or Stefan Loren, Westwicke Partners, +1-443-213-0507 Web Site: http://www.westpharma.com/

Copyright